Pharmaceutical Executive Daily: Novo Nordisk's Amended Acquisition Proposal
Nov 6, 2025
03:10
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s amended proposal to acquire Metsera, the State of Texas’ attempt to block Kenvue’s planned dividend payment, and how data and AI are transforming pharma’s next frontier in commercial customer engagement.
Pharmaceutical Executive